Executive order by US administration excludes Pharma sector from immediate tariff imposition: Indian Pharmaceutical Alliance

The Indian pharmaceutical sector has been excluded from immediate US tariff hikes due to the importance of generic medicines for affordable healthcare in the United States. This follows President Trump's imposition of a 25% tariff on India over Russian oil purchases, raising the total tariff to 50%.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bkQCuVn
via IFTTT